# FDA Inspection 1279225 - Haresh D. Boghara - August 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/haresh-d-boghara/b4d8d517-b843-48a8-a9ef-11abee128761
Source feed: FDA_Inspections

> FDA Inspection 1279225 for Haresh D. Boghara on August 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1279225
- Company Name: Haresh D. Boghara
- Inspection Date: 2025-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279225 - 2025-08-14](https://www.keypedia.com/records/fda_inspections/haresh-d-boghara/e5693e77-88b9-44d9-b58c-46ef01a15a74)

Company: https://www.keypedia.com/companies/haresh-d-boghara/5ded088e-be9d-4f34-b0ae-035f1e6f5504

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d